Tolerability profile of bevacizumab in metastatic colorectal cancer: about a Medical Department experience

Colorectal cancer is one of the most common cancers worldwide, and associated with high mortality rates in our country. The prognosis of patients diagnosed with metastatic colorectal cancer (mCRC) has improved markedly over the last 12 years, increasing from 5 months with best supportive care to alm...

Descripción completa

Detalles Bibliográficos
Autores principales: Khmamouche, Mohamed Reda, Mahfoud, Tarik, Bazine, Aziz, Tanz, Rachid, Ichou, Mohamed, Errihani, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2016
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325501/
https://www.ncbi.nlm.nih.gov/pubmed/28292081
http://dx.doi.org/10.11604/pamj.2016.25.118.2266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325501/
https://www.ncbi.nlm.nih.gov/pubmed/28292081
http://dx.doi.org/10.11604/pamj.2016.25.118.2266

Ejemplares similares